Douglas C. Behenna - Concepedia

Author

Douglas C. Behenna

Also Known As

Behenna, D.C., Behenna, Douglas C., D. Behenna, Douglas Behenna, Douglas C Behenna, Douglas C. Behenna, Douglas C. Behenna

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

California Institute of Technology Pfizer (United States)Johnson Foundation University of Pennsylvania Beckman Research Institute

About

Douglas C. Behenna is an author at California Institute of Technology specializing in chemistry, engineering, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	13	13	2K
2	Natural Sciences	10	10	875
3	Medicine	4	4	336
4	Biochemistry	3	3	101
5	Health Sciences	1	1	60

Douglas C. Behenna

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
The Enantioselective Tsuji Allylation Douglas C. Behenna, Brian M. Stoltz Journal of the American Chemical Society Enantioselective Tsuji AllylationChemical EngineeringEnol SilanesEngineeringCross-coupling Reaction	2004	549
Deracemization of Quaternary Stereocenters by Pd‐Catalyzed Enantioconvergent Decarboxylative Allylation of Racemic β‐Ketoesters Justin T. Mohr, Douglas C. Behenna, Andrew M. Harned, Angewandte Chemie International Edition Cc Bond-breakingRacemic β‐KetoestersEngineeringSingle Cascade ReactionNatural Sciences	2005	374
Enantioselective construction of quaternary N-heterocycles by palladium-catalysed decarboxylative allylic alkylation of lactams Douglas C. Behenna, Yiyang Liu, Taiga Yurino, Nature Chemistry Chemical EngineeringEngineeringQuaternary N-heterocyclesOrganic ChemistryCatalysis	2011	241
Enantioselective Decarboxylative Alkylation Reactions: Catalyst Development, Substrate Scope, and Mechanistic Studies Douglas C. Behenna, Justin T. Mohr, Nathaniel H. Sherden, Chemistry - A European Journal Prochiral Enolateα-Quaternary KetonesMechanistic StudiesPalladium CenterEngineering	2011	201
Expanding control of the tumor cell cycle with a CDK2/4/6 inhibitor Kevin D. Freeman‐Cook, Robert L. Hoffman, Nichol Miller, Cancer Cell Tumor BiologyOncologyCdk2/4/6 InhibitorMedicineTumor Cell Cycle	2021	172
Catalytic Enantioselective Decarboxylative Protonation Justin T. Mohr, Toyoki Nishimata, Douglas C. Behenna, Journal of the American Chemical Society	2006	148
The Inner-Sphere Process in the Enantioselective Tsuji Allylation Reaction with (<i>S</i>)-<i>t</i>-Bu-phosphinooxazoline Ligands John A. Keith, Douglas C. Behenna, Justin T. Mohr, Journal of the American Chemical Society Inner-sphere ProcessCross-coupling ReactionEngineeringNatural SciencesInner-sphere Mechanism	2007	140
Deracemization of Quaternary Stereocenters by Pd‐Catalyzed Enantioconvergent Decarboxylative Allylation of Racemic β‐Ketoesters Justin T. Mohr, Douglas C. Behenna, Andrew M. Harned, Angewandte Chemie Racemic β‐KetoestersEngineeringQuartäre KohlenstoffstereozentrenQuaternary StereocentersOrganic Chemistry	2005	130
The Reaction Mechanism of the Enantioselective Tsuji Allylation: Inner-Sphere and Outer-Sphere Pathways, Internal Rearrangements, and Asymmetric C–C Bond Formation John A. Keith, Douglas C. Behenna, Nathaniel H. Sherden, Journal of the American Chemical Society	2012	124
A Facile and Modular Synthesis of Phosphinooxazoline Ligands Kousuke Tani, Douglas C. Behenna, Ryan M. L. McFadden, Organic Letters Inorganic ChemistryChemical EngineeringPhosphine/aryl HalideEngineeringCoordination Complex	2007	120

Page 1